Novartis AG vs Southern Copper Corp — how do they compare? Novartis AG trades at $152.4 (market cap $295.37B), while Southern Copper Corp trades at $197 (market cap $164.21B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NVS | SCCO | |
|---|---|---|
Market Cap | $295.37B | $164.21B |
Sector | Health | Basic Materials |
52-Week High | $168.62 | $218.85 |
52-Week Low | $119.31 | $93.70 |
Enterprise Value | $336.69B | $165.50B |
Dividend Yield | 3.07% | 2.26% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →